Arndt Vogel路 @ArndtVogel 路 X路路 2 days agoScore70
Body 路 original
Anbenitamab plus chemotherapy for previously treated HER2-positive GC/GEJC: Updated OS analysis of KC-WISE 馃嚚馃嚦
#ESMO26 #ESMOAmbassadors
馃憠 ORR: 56 vs 13%
馃憠 mOS: 19.6 vs 9.7 mo
馃憠no unexpected safety signal
馃Supports sequential targeting of Her2
@myESMO @ASCO
921 views 路 18 likes 路 7 reposts 路 0 replies
Conference abstracts
LBA15matched by Proffered paper 2: Breast cancer, early and advanced stage
Anbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.orgLBA80matched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Anbenitamab plus chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Updated overall survival (OS) analysis of KC-WISE
https://esmocongress.esmo.orgSource: Arndt Vogel 路 x.com